Matthew Parisi

Analyst

KeyBanc Capital Markets

Equibles does not estimate personal net worth.

About Matthew Parisi

Matthew Parisi is recorded as Analyst at KeyBanc Capital Markets. Matthew Parisi has spoken on 6 earnings calls across 4 companies, most recently for Maravai Lifesciences Holdings, Inc. on August 6, 2026. Those appearances were for Maravai Lifesciences Holdings, Inc. (MRVI), Exagen Inc. (XGN), Castle Biosciences Inc (CSTL) and Alpha Teknova, Inc. (TKNO). The companies whose calls Matthew Parisi spoke on are classified in the Healthcare sector.

Matthew Parisi on recent calls

“I'm for Palm Night at KeyBank Capital Markets. You highlighted the incredible uptick in discovery. And I was wondering if you're seeing that come through from the improved biotech funding, or is that improved funding not really translating to revenue yet?”

Analyst — KeyBanc Capital Markets, Q2 2026 Maravai LifeSciences Earnings Conference Call · August 6, 2026

“I was wondering if you could give an update regarding the local coverage determination. Last we heard, there was an expectation of an update in mid to late 2026.”

Analyst — KeyBanc Capital Markets, Q2 2026 Earnings Call · August 4, 2026

“You guys had a pickup in SEC volumes for the first time since it lost coverage and stopped marketing the test. Could you provide some color on what is driving the resurgence?”

Analyst — KeyBanc Capital Markets, Castle Biosciences Q2 2026 Earnings Call · July 30, 2026

“As a percentage of revenue, APAC decreased pretty meaningfully in the quarter compared to the fourth quarter. I was wondering what drove that change and then is that a trend that you can expect for the rest of 2026?”

Analyst — KeyBanc Capital Markets, Maravai Lifesciences Holdings, Inc. Q1 FY2026 Earnings Call · May 7, 2026